Next Article in Journal
Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer
Next Article in Special Issue
Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies
Previous Article in Journal
Photodynamic Anti-Bacteria by Carbon Dots and Their Nano-Composites
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(4), 488; https://doi.org/10.3390/ph15040488
Action Date Notes Link
article xml file uploaded 18 April 2022 10:08 CEST Original file -
article xml uploaded. 18 April 2022 10:08 CEST Update https://www.mdpi.com/1424-8247/15/4/488/xml
article pdf uploaded. 18 April 2022 10:08 CEST Version of Record https://www.mdpi.com/1424-8247/15/4/488/pdf
article html file updated 18 April 2022 10:09 CEST Original file -
article html file updated 18 April 2022 10:36 CEST Update -
article html file updated 18 April 2022 10:37 CEST Update -
article html file updated 2 August 2022 19:26 CEST Update https://www.mdpi.com/1424-8247/15/4/488/html
Back to TopTop